These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 25944426)
1. Lymphovascular invasion: a comprehensive appraisal in colon and rectal adenocarcinoma. Hogan J; Chang KH; Duff G; Samaha G; Kelly N; Burton M; Burton E; Coffey JC Dis Colon Rectum; 2015 Jun; 58(6):547-55. PubMed ID: 25944426 [TBL] [Abstract][Full Text] [Related]
2. The Impact of Preoperative Radiation Therapy on Locoregional Recurrence in Patients with Stage IV Rectal Cancer Treated with Definitive Surgical Resection and Contemporary Chemotherapy. Manyam BV; Mallick IH; Abdel-Wahab MM; Reddy CA; Remzi FH; Kalady MF; Lavery I; Koyfman SA J Gastrointest Surg; 2015 Sep; 19(9):1676-83. PubMed ID: 26014718 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic management and outcome of locoregional recurrence after curative colorectal cancer therapy-a single-center analysis. Kogler P; Kafka-Ritsch R; Sieb M; Sztankay A; Pratschke J; Zitt M J Gastrointest Surg; 2014 Nov; 18(11):2026-33. PubMed ID: 25159503 [TBL] [Abstract][Full Text] [Related]
4. Factors predicting recurrence after curative resection for rectal cancer: a 16-year study. Farhat W; Azzaza M; Mizouni A; Ammar H; Ben Ltaifa M; Lagha S; Kahloul M; Gupta R; Mabrouk MB; Ali AB World J Surg Oncol; 2019 Oct; 17(1):173. PubMed ID: 31660992 [TBL] [Abstract][Full Text] [Related]
5. Who should get a right colectomy in low-grade appendiceal adenocarcinomas? Association of lymphovascular invasion and nodal metastases. Waheed MT; Malik I; Blakely AM; Zerhouni Y; Hanna M; Melstrom K; Lai LL; Kaiser AM; Thinzar L; Paz IB; Raoof M Surgery; 2024 Sep; 176(3):560-568. PubMed ID: 38987096 [TBL] [Abstract][Full Text] [Related]
6. Risk of recurrence in high-risk T1 colon cancer following endoscopic and surgical resection: registry-based cohort study. Nilsson E; Wetterholm E; Syk I; Thorlacius H; Rönnow CF BJS Open; 2024 May; 8(3):. PubMed ID: 38869239 [TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of patients with locally resected high- and low-risk rectal carcinoid tumors. Shigeta K; Okabayashi K; Hasegawa H; Ishii Y; Ochiai H; Tsuruta M; Mukai M; Kameyama K; Uraoka T; Yahagi N; Kitagawa Y J Gastrointest Surg; 2014 Apr; 18(4):768-73. PubMed ID: 24519035 [TBL] [Abstract][Full Text] [Related]
8. Implications of pretreatment extramural venous invasion in rectal cancer patients: A population-based study. Rutegård M; Matthiessen P; Glimelius B; Blomqvist L Colorectal Dis; 2024 Jul; 26(7):1388-1396. PubMed ID: 38849298 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic assessments and treatment results of well-differentiated gastric-type adenocarcinoma of the uterine cervix (Adenoma malignum): A multicenter retrospective analysis of KROG 22-03 study. Choi KH; Lee HC; Kim YS; Park W; Kim YB; Jung W; Kim KS; Eom KY; Kim JH; Lee JH Gynecol Oncol; 2024 Mar; 182():45-50. PubMed ID: 38246046 [TBL] [Abstract][Full Text] [Related]
10. Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum. Washington MK; Berlin J; Branton P; Burgart LJ; Carter DK; Fitzgibbons PL; Halling K; Frankel W; Jessup J; Kakar S; Minsky B; Nakhleh R; Compton CC; Arch Pathol Lab Med; 2009 Oct; 133(10):1539-51. PubMed ID: 19792043 [No Abstract] [Full Text] [Related]
11. The Incidence and Prognosis Value of Perineural Invasion in Rectal Carcinoma: From Meta-Analyses and Real-World Clinical Pathological Features. Chen T; Zheng B; Yang P; Zhang Z; Su Y; Chen Y; Luo L; Luo D; Lin Y; Xie R; Zeng L Clin Oncol (R Coll Radiol); 2023 Oct; 35(10):e611-e621. PubMed ID: 37263883 [TBL] [Abstract][Full Text] [Related]
12. Differences in Factors Predicting Lymph Node Metastasis Between pT1 Rectal Cancer and pT1 Colon Cancer: A Retrospective Study. Cho SH; Park BS; Son GM; Kim HS; Kim SJ; Park SB; Choi CW; Kim HW; Shin DH; Yun MS Am Surg; 2023 Dec; 89(12):5829-5836. PubMed ID: 35766839 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of preoperative radiological staging assessed by computed tomography in patients with nonmetastatic colon cancer. Huh JW; Jeong YY; Kim HR; Kim YJ Ann Oncol; 2012 May; 23(5):1198-1206. PubMed ID: 21948813 [TBL] [Abstract][Full Text] [Related]
14. Is there no need to discuss adjuvant chemotherapy in stage II colon cancer patients with high tumor budding and lymphovascular invasion? Zenger S; Gurbuz B; Can U; Erginoz E; Ozata IH; Yilmaz SP; Taskin OC; Peker O; Adsay V; Balik E; Bugra D Langenbecks Arch Surg; 2023 Mar; 408(1):127. PubMed ID: 36973561 [TBL] [Abstract][Full Text] [Related]
15. Negative Prognostic Impact of Tumor Deposits in Rectal Cancer: A National Study Cohort. Agger E; Jörgren F; Jöud A; Lydrup ML; Buchwald P Ann Surg; 2023 Sep; 278(3):e526-e533. PubMed ID: 36538637 [TBL] [Abstract][Full Text] [Related]
16. Surveillance Intensity Comparison by Risk for T1NX Locally Excised Rectal Adenocarcinoma: a Cost-Effective Analysis. McCain M; O'Neill Y; Hernandez H; Foley R; Sadowski BM; Torgersen Z; Beaty J; Payacan RR; Ternent CA J Gastrointest Surg; 2020 Jan; 24(1):198-208. PubMed ID: 31724115 [TBL] [Abstract][Full Text] [Related]
17. Exploring the impact of stage and tumor site on colorectal cancer survival: Bayesian survival modeling. Alinia S; Ahmadi S; Mohammadi Z; Rastkar Shirvandeh F; Asghari-Jafarabadi M; Mahmoudi L; Safari M; Roshanaei G Sci Rep; 2024 Feb; 14(1):4270. PubMed ID: 38383712 [TBL] [Abstract][Full Text] [Related]
18. Risk of colon cancer recurrence in relation to diabetes. Chubak J; Yu O; Ziebell RA; Bowles EJA; Sterrett AT; Fujii MM; Boggs JM; Burnett-Hartman AN; Boudreau DM; Chen L; Floyd JS; Ritzwoller DP; Hubbard RA Cancer Causes Control; 2018 Nov; 29(11):1093-1103. PubMed ID: 30244297 [TBL] [Abstract][Full Text] [Related]
19. PFKFB3 overexpression in monocytes of patients with colon but not rectal cancer programs pro-tumor macrophages and is indicative for higher risk of tumor relapse. Larionova I; Patysheva M; Iamshchikov P; Kazakova E; Kazakova A; Rakina M; Grigoryeva E; Tarasova A; Afanasiev S; Bezgodova N; Kiselev A; Dobrodeev A; Kostromitskiy D; Cherdyntseva N; Kzhyshkowska J Front Immunol; 2022; 13():1080501. PubMed ID: 36733385 [TBL] [Abstract][Full Text] [Related]
20. Necl 4 and RNase 5 Are Important Biomarkers for Gastric and Colon Adenocarcinomas. Sayar İ; Gökçe A; Demirtas L; Eken H; Çimen FK; Çimen O Med Sci Monit; 2017 May; 23():2654-2659. PubMed ID: 28561015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]